These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9330784)
1. Effect of food on the bioavailability of fexofenadine hydrochloride (MDL 16455A). Stoltz M; Arumugham T; Lippert C; Yu D; Bhargava V; Eller M; Weir S Biopharm Drug Dispos; 1997 Oct; 18(7):645-8. PubMed ID: 9330784 [No Abstract] [Full Text] [Related]
2. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. Jin MJ; Han HK J Food Sci; 2010 Apr; 75(3):H93-6. PubMed ID: 20492299 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers. Russell T; Stoltz M; Weir S Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426 [TBL] [Abstract][Full Text] [Related]
4. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Dresser GK; Kim RB; Bailey DG Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611 [TBL] [Abstract][Full Text] [Related]
5. Effect of fruit juices on the oral bioavailability of fexofenadine in rats. Kamath AV; Yao M; Zhang Y; Chong S J Pharm Sci; 2005 Feb; 94(2):233-9. PubMed ID: 15570603 [TBL] [Abstract][Full Text] [Related]
6. Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. Petri N; Borga O; Nyberg L; Hedeland M; Bondesson U; Lennernas H Int J Clin Pharmacol Ther; 2006 Feb; 44(2):71-9. PubMed ID: 16502766 [TBL] [Abstract][Full Text] [Related]
7. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine. Banfield C; Gupta S; Marino M; Lim J; Affrime M Clin Pharmacokinet; 2002; 41(4):311-8. PubMed ID: 11978146 [TBL] [Abstract][Full Text] [Related]
8. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability. Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Houston B; Oosterhuis B; Bjerrum OJ; Rowland M; Garner C Eur J Pharm Sci; 2010 May; 40(2):125-31. PubMed ID: 20307657 [TBL] [Abstract][Full Text] [Related]
10. Absence of food effects on the pharmacokinetics of terfenadine. Eller MG; Walker BJ; Yuh L; Antony KK; McNutt BE; Okerholm RA Biopharm Drug Dispos; 1992 Apr; 13(3):171-7. PubMed ID: 1576325 [TBL] [Abstract][Full Text] [Related]
11. Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455) and its enantiomers in healthy male volunteers. Robbins DK; Castles MA; Pack DJ; Bhargava VO; Weir SJ Biopharm Drug Dispos; 1998 Oct; 19(7):455-63. PubMed ID: 9818712 [TBL] [Abstract][Full Text] [Related]
12. Effect of diosmin on the intestinal absorption and pharmacokinetics of fexofenadine in rats. Neerati P; Bedada SK Pharmacol Rep; 2015 Apr; 67(2):339-44. PubMed ID: 25712660 [TBL] [Abstract][Full Text] [Related]
13. Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation. Bedada SK; Appani R; Boga PK Drug Dev Ind Pharm; 2017 Jun; 43(6):932-938. PubMed ID: 28102715 [TBL] [Abstract][Full Text] [Related]
14. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment. Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667 [TBL] [Abstract][Full Text] [Related]
15. Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A. Peng SX; Ritchie DM; Cousineau M; Danser E; Dewire R; Floden J J Pharm Sci; 2006 Sep; 95(9):1984-93. PubMed ID: 16850393 [TBL] [Abstract][Full Text] [Related]
16. Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometry. Hofmann U; Seiler M; Drescher S; Fromm MF J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):227-33. PubMed ID: 11824810 [TBL] [Abstract][Full Text] [Related]
17. Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers. Akamine Y; Miura M; Komori H; Saito S; Kusuhara H; Tamai I; Ieiri I; Uno T; Yasui-Furukori N Eur J Clin Pharmacol; 2014 Sep; 70(9):1087-95. PubMed ID: 24903351 [TBL] [Abstract][Full Text] [Related]
18. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. Tannergren C; Knutson T; Knutson L; Lennernäs H Br J Clin Pharmacol; 2003 Feb; 55(2):182-90. PubMed ID: 12580990 [TBL] [Abstract][Full Text] [Related]
19. Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine. Ohura K; Soejima T; Nogata R; Adachi Y; Ninomiya S; Imai T J Pharm Sci; 2012 Sep; 101(9):3264-74. PubMed ID: 22628163 [TBL] [Abstract][Full Text] [Related]
20. Some pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humans. Chen C Drugs R D; 2007; 8(5):301-14. PubMed ID: 17767395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]